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Complicated pregnancies in inherited distal renal tubular acidosis: Importance of acid-
base balance  
 
Abstract 
Inherited distal renal tubular acidosis (dRTA) is caused by impaired urinary acid excretion resulting in 
hyperchloremic metabolic acidosis. Although glomerular filtration rate is usually preserved, and hypertension 
and overt proteinuria are absent, it has to be considered that patients with dRTA also suffer from chronic kidney 
disease (CKD) with an increased risk for adverse pregnancy-related outcomes. Typical complications of dRTA 
include severe hypokalemia leading to cardiac arrhythmias and paralysis, nephrolithiasis and nephrocalcinosis. 
Several physiologic changes occur in normal pregnancy including alterations in acid base and electrolyte 
homeostasisas well as in GFR. However, data on pregnancy in women with inherited dRTA are scarce. We 
report the course of pregnancy in three women with hereditary dRTA. Complications observed were severe 
metabolic acidosis, profound hypokalemia aggravated by hyperemesis gravidarum, recurrent urinary tract 
infection and ureteric obstruction leading to renal failure. However, the outcome of all five pregnancies was 
excellent due to timely interventions. Our findings highlight the importance of close nephrologic monitoring of 
women with inherited dRTA during pregnancy. In addition to routine assessment of creatinine and proteinuria, 
caregivers should especially focus on acid base status, plasma potassium and urinary tract infections. Patients 
should be screened for renal obstruction in case of typical symptoms, UTI or renal failure. Furthermore, genetic 
identification of the underlying mutation may i) support early nephrologic referral during pregnancy and a better 
management of the affected woman and ii) help to avoid delayed diagnosis and reduce complications in affected 
newborns. 
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Introduction 
Distal renal tubular acidosis (dRTA) refers to a group of tubular disorders causing disturbances in acid-base 
homeostasis and is characterized by defective urinary acid excretion resulting in hyperchloremic metabolic 
acidosis with inappropriate alkaline urine1. dRTA is either inherited, acquired or idiopathic. Mutations in three 
different genes have been implicated in hereditary autosomal recessive or dominant dRTA, namely SLC4A1, 
ATP6V1B1, and ATP6V0A41. In recessive forms, clinical manifestation usually occurs during early infancy or 
childhood and includes failure to thrive, dehydration, nephrocalcinosis, and rickets. In dominant forms, clinical 
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manifestation typically occurs in young adults and includes nephrolithiasis and osteoporosis or osteomalacia. 
Other major complications include severe hypokalemia resulting in paralysis, rhabdomyolysis or life-threatening 
arrhythmia2,3. Therapy includes lifetime treatment with potassium citrate and/or sodium bicarbonate to prevent 
growth retardation in children, kidney stone formation, and progression of nephrocalcinosis.  
It has been reported that female CKD patients are at increased risk for complications during pregnancy and 
therefore close interdisciplinary monitoring is essential in this vulnerable population4-6. However, individuals 
with tubulopathies such as dRTA usually have a preserved eGFR and thus are often not perceived as CKD 
patients. Subsequently, monitoring and treatment during pregnancy may be insufficient. By now, no systematic 
data exist on the course of pregnancy in hereditary dRTA affected mothers and both, mother and child outcome. 
Single case reports have reported pregnancy in several types of RTA (proximal, distal, inherited, secondary) to 
be predominantly complicated by hypokalemia7-9 or hypertension10. Here, we report a series of three women 
with inherited dRTA developing several complications during pregnancy. 
 
Case 1 
The 30-year-old woman was diagnosed with dRTA at 4 months because of failure to thrive and vomiting11. She 
also suffered from sensorineural hearing loss (SNHL) and hearing aids were introduced at the age of 3.5 years 
(Table 1). She had a history of bilateral nephrocalcinosis and a non-functioning left kidney due to vesicoureteral 
reflux. Estimated glomerular filtration rate (eGFR) has been stable in the normal range since she was diagnosed 
with dRTA. Her long-term medication consisted of potassium citrate (20 mEq tid) and sodium bicarbonate (1000 
mg tid). At age 29 she became pregnant for the first time. The gestation period was complicated by severe 
urinary tract infections (UTI) and pyelonephritis requiring repeated antibiotic treatment. Further, she developed 
urinary tract obstruction and was subjected to right-sided ureteric stenting and subsequent antibiotic prophylaxis 
during the second and third trimenon (Table 1). Patients with nephrocalcinosis are more prone to develop UTIs12. 
Since the obstruction in our patient occurred early in the second trimenon she did not undergo CT scan to 
distinguish between a ureteric calculus or an inflammatory stricture, therefore the etiology remained unclear. Our 
patient reported regular intake and good tolerance of potassium citrate and sodium bicarbonate during the whole 
period of pregnancy. However, she developed hypokalemia and low bicarbonate levels during pregnancy (Table 
1), that may be caused by either a higher demand of alkali supplementation during pregnancy or malcompliance. 
At term she delivered a healthy female newborn by cesarean section. Postnatal investigation of the newborn 
showed no abnormalities (Table 2).    
 
Case 2 
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The 26-year-old woman was hospitalized in Zagreb at the age of 12 months where she was diagnosed with 
dRTA and SNHL (Table 1)11. Her eGFR has always been in the normal range and no kidney stones or UTIs were 
observed. However, her first pregnancy at the age of 22 was complicated by hypokalemia and aggravation of 
metabolic acidosis especially during the first trimenon because of discontinuation of potassium citrate (2500 mg 
tid) due to hyperemesis gravidarum. In addition, the patient had not restarted potassium citrate after the first 
trimenon since she was afraid of her sickness to recur. Rescue therapy with e.g. intravenous alkali 
supplementation could not be applied because the patient was referred to her nephrologist after all complaints 
had already ceased. Fortunately, the prenatal course was otherwise uneventful. She delivered a healthy male 
infant by cesarean section at term (Table 2). To date, pediatric follow-up showed normal development.        
  
Case 3 
The 32-year-old woman, who was expecting her third child after having two healthy children and one 
miscarriage (gravida 4, para 3), had been diagnosed with dRTA at the age of 18 months. Subsequently she was 
supplemented with potassium citrate and sodium bicarbonate. As expected she developed nephrocalcinosis and 
osteopenia but no hearing abnormalities. Estimated glomerular filtration rate was slighty reduced since 2011 
with an eGFR below 90 ml/min (Table 1). Her first pregnancy was in 2008 and was terminated by curettage 
because of a missed abortion. Second and third pregnancies required hospital admission because of severe 
muscular weakness and profound hypokalemia (serum potassium <2 mmol/l). Additionally, she had recurrent 
episodes of flank pain due to hydronephrosis at 30 weeks gestation during her third pregnancy. Both pregnancies 
ended uneventfully by vaginal delivery of two healthy girls (Table 2). In 2014, during the fourth pregnancy she 
repeatedly developed symptomatic hypokalemia and decompensated metabolic acidosis after stopping potassium 
citrate because of hyperemesis. In addition, liver function parameters were elevated in the last trimenon 
suspicious of preeclampsia or HELLP (hemolysis, elevated liver, low platelet) syndrome and labour was induced 
3 weeks before due date. Also this time she had an uncomplicated delivery of a female newborn by vaginal 
route. Notably, this patient was not regularly seen by a  nephrologist during her former pregnancies and no 
genetic testing had been performed yet. During her fourth pregnancy, she was treated by a new nephrologist who 
contacted us as a tertiary care center to guide therapy and further diagnostic procedures. After delivery, genetic 
analysis of the mother was performed in a laboratory with long-standing expertise in tubulopathies and revealed 
a heterozygous mutation in the SLC4A1 gene (c.1766G>A, p.Arg589His) (Table 1). Based on the dominant 
inheritance pattern genetic analysis was consequently performed in all three children and the same mutation was 
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detected in the last-born child (Table 2). This 18-months-old infant is suffering from failure to thrive, 
nephrocalcinosis and metabolic acidosis (Table 2). 
 
Discussion 
Distal renal tubular acidosis is a tubular disorder defined by normal anion gap metabolic acidosis and 
inappropriate alkaline urine, both caused by the reduced capacity of the kidneys to excrete ammonium and 
acids1. Mutations in three different genes have been so far implicated in dRTA, namely SLC4A1, ATP6V1B1, 
and ATP6V0A4, all encoding for proteins that are expressed in the acid-secretory cells of the collecting duct and 
play a crucial role in distal urine acid excretion1. SLC4A1 mutations are mostly inherited in an autosomal 
dominant manner and have a high prevalence in some Southeast Asian countries, where the disease is 
predominantly caused by recessive mutations13. Some patients with recessive SLC4A1 mutations may develop 
hemolytic disease such as Southeast Asian Ovalocytosis13. Interestingly, most patients with recessive mutations 
present either with dRTA or hemolytic disease, and only in rare instances with a combination of both 
phenotypes1. The p.Arg589His mutation is among the most common SLC4A1 mutations in autosomal dominant 
dRTA as also detected in our patient14. ATP6V1B1 and ATP6V0A4 are two different subunits of the vacuolar H+-
ATPase and mutations are inherited in an autosomal recessive manner. Heterozygous mutations may underlie 
forms of incomplete dRTA15. Affected individuals with recessive dRTA are usually diagnosed during infancy or 
childhood presenting with failure to thrive and rickets resulting from profound hyperchloremic metabolic 
acidosis16,17. Further, patients present with nephrolithiasis and/or nephrocalcinosis, hearing abnormalities 
(SNHL), and occasionally abnormal widening of the vestibular aqueduct11. Rarely patients develop chronic renal 
failure that may result from progressive nephrocalcinosis but the underlying pathomechanisms are not 
completely understood. Other serious complications such as severe hypokalemia resulting in paralysis, 
rhabdomyolysis, or life-threatening arrhythmia are frequently reported highlighting the importance of lifelong 
alkali treatment with potassium citrate and/or sodium bicarbonate2,3. Alkali therapy is also aimed to prevent 
growth retardation in children, kidney stone formation, bone disease and progression of nephrocalcinosis, 
although adherence to therapy is often attenuated because of gastrointestinal side effects of potassium citrate. 
Unfortunately, there is no benefit of alkali therapy on hearing abnormalities16. eGFR is usually preserved in 
individuals with dRTA, however, they suffer from CKD due to tubular dysfunction18 and are at high risk for 
adverse pregnancy-related outcomes4-6. Precisely because of normal eGFR and lack of albuminuria, 
caregivers/gynecologists/obstetricians may overlook other typical complications during pregnancy such as 
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severe hypokalemia and worsening of metabolic acidosis and underestimate the importance of early nephrologic 
referral and the need for interdisciplinary management of pregnant women with dRTA.  
To date, little is known about the impact of inherited forms of dRTA on pregnancy including mother and child 
outcome Several physiologic changes concerning kidney function occur during pregnancy such as increase in 
glomerular filtration rate19. Respiratory alkalosis with subsequent increased renal bicarbonate excretion is the 
main acid-base alteration in pregnancy20. Under normal conditions both mother and fetus adapt well to the fall in 
pCO2 and bicarbonate. However, maternal acidosis as reported in our patient series may have several 
unfavorable effects on the fetus if untreated or diagnosis is delayed20,21. First, oxygen supply via the placenta 
may be attenuated due to vasoconstriction of uterine vessels causing fetal distress7,21. Second, maternal metabolic 
acidosis may impair fetal bone growth and development7,8. Two of our patients suffered from severe 
hyperemesis gravidarum and temporarily stopped alkali supplementation resulting in exacerbation of the 
metabolic acidosis and profound hypokalemia. Furthermore, lower plasma bicarbonate may also be explained by 
increased filtration of bicarbonate as a consequence of pregnancy-related increase in eGFR19. However, both 
hypokalemia and decrease in serum bicarbonate were also present in our first case who apparently continued her 
alkali treatment suggesting that patients with dRTA may require higher doses of potassium and alkali therapy 
during pregnancy. This has also been observed by others8. Additionally, severe hypokalemia may result in 
paralysis and eventually rhabdomyolysis as reported in several case reports of pregnant women with RTA. This 
was not observed in our patients potentially due to close monitoring and timely treatment7,9. One of our patients 
was additionally suffering from recurrent UTI and obstruction requiring long-term antibiotic treatment and 
ureteric stenting. Nephrocalcinosis and kidney stones as typical clinical findings in these patients may increase 
the risk of UTI in pregnant dRTA patients in addition to general physiologic changes of the urinary tract during 
pregnancy therefore predisposing pregnant women to UTI including pyelonephritis. In contrast to Rowe et al. 
none of our patients developed hypertension during pregnancy and kidney function remained stable post-
partum10. Fortunately, all deliveries were uneventful with healthy term neonates as reported in the literature7-10 
suggesting no adverse impact on child outcome in RTA patients.  
In our case series, case 1 and 2 had been genetically tested before pregnancy and subsequently subjected to 
genetic counseling. Case 3 was referred to our center after having 3 children and genetic testing was initiated by 
us after her third delivery. Unfortunately no genetic counseling was provided to this patient before pregnancy. In 
our opinion, genetic testing is strongly recommended in all pregnant women with inherited dRTA and unknown 
underlying mutation to provide pre- or at least post-conceptional counseling and to avoid delayed diagnosis and 
treatment in potentially affected infants, particularly in patients with the autosomal dominant form and in 
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consanguineous couples. The analysis should be performed in laboratories with expertise on renal tubular 
diseases. Additionally, early nephrologic referral and interdisciplinary management are inevitable in pregnant 
women with clinically diagnosed or suspected inherited dRTA.  
In conclusion, women with inherited dRTA are at high risk to develop hypokalemia and exacerbation of 
metabolic acidosis during pregnancy. Additionally, they are predisposed to UTI and other urologic 
complications. Thus, in addition to regular monitoring of creatinine and proteinuria as for all women with CKD, 
in particular close monitoring of acid-base (assessed by blood gas analysis) and electrolyte status (including 
sodium, potassium, chloride, and magnesium) is required to prevent life-threatening hypokalemia and 
decompensation of metabolic acidosis. Further, affected individuals should be thoroughly screened for UTI or 
obstruction if deterioration of renal function occurs. Additionally, we recommend early nephrologic referral and 
interdisciplinary management for all pregnant women with clinically diagnosed or suspected dRTA. Finally, 
timely genetic testing should be performed to provide pre- or post-conceptional counseling to affected women 
and early diagnosis, identification and treatment of complications in affected newborns. 
 
Informed Consent 
Written informed consent was obtained from all patients for publication.  
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Table 1. Clinical and laboratory characteristics of the patients 
 Mother 1  Mother 2  Mother 3  
Age at diagnosis 4 months 12 months 18 months 
Nephrocalcinosis y y y 
SNHL y y n 
Age at current 
pregnancy 
30 22 31 
No of 
Pregnancies  
1 1 4 
No of children 1 1 3 
No of children 
affected 
0 0 1 
Gene ATP6V1B1 ATP6V1B1 SLC4A1 
Mutation c.242T>C, p.Leu81Pro 
c.481G>A, p.Glu161Lys 
(double homozygous) 
c.242T>C, p.Leu81Pro 
c.1037C>G, p.Pro346Arg 
(compound hetereozygous) 
c.1766G>A, p.Arg589His 
Inheritance recessive recessive dominant 
Laboratory 
parameters 
Before 
pregnancy 
During 
pregnancy 
After 
pregnancy 
Before 
pregnancy 
During 
pregnancy 
After 
pregnancy 
Before 
pregnancy 
During 
pregnancy 
After 
pregnancy 
Potassium, 
mmol/l 
3.6 3.0 3.5 3.6 3.3 3.6 4.3 2.1 3.5 
Creatinine, umol/l 72 68 73 63 48 67 100 108 125 
eGFR (CKD-
EPI), ml/min 
98 104 96 121 134 111 66 60 50 
Change of eGFR 
in % of baseline 
eGFR 
- +5.8 -2.0 - +10.7 -8.3 - -9.1 -24.2 
Blood pH 7.35 7.36 7.44 7.35 7.43 7.35 7.37 7.27 7.25 
Bicarbonate, 
mmol/l 
23 15 25 28 21 24 24 11 19 
Plasma anion gap 8.0 9.7 n.d. 8.4 6.3 8.0 n.d. 9.0 n.d. 
Plasma lactate 2.0 1.5 n.d. 1.2 1.7 0.7 n.d. 0.6 n.d. 
2 
 
Chloride, mmol/l 108 113 n.d. 105 108 109 n.d. 120 n.d. 
Urine pH 7.5 8.0 8.5 8.0 8.0 7.5 8.0 7.0 7.0 
Hemoglobin, g/l 131 128 107 138 115 136 125 143 124 
Polyhydramnios - n - - n - - n - 
Kidney stones n n n n n n n n n 
UTI sporadic y n n Asymptomatic 
leukocyturia 
n y y n 
Obstruction n 
 
y (ureteric 
stenting) 
n n n n n y n 
Treatment Potassium citrate,  
sodium bicarbonate 
Potassium citrate 
 
Potassium citrate,  
sodium bicarbonate 
y: yes, n: no, n.d.: not determined, SNHL: sensorineural hearing loss , UTI: urinary tract infection 
 
 
Table 2. Laboratory and clinical data of the children 
 1
st
 Child of mother 1 1
st
 Child of mother 2 1
st
 Child of mother 3 2
nd
 child of mother 3 3
rd
 Child of mother 3 
Gestational age at birth 38+2 38+4  40+2 38+5 37+3 
Gender female male female female female 
Mode of delivery elective cesarean section elective cesarean section vaginal vaginal vaginal 
Birth weight, g 3280 3230  3130 2880 2790 
Height, cm  47 50 52  
(at 1 month) 
47  46  
Blood pH 7.41 7.33 7.41 (at 1 month) 7.30 7.36  
(at 1 month) 
Urine pH 6.0 n.d. 7.0 (at 4 months) 7.0 (at 1 year) 7.0 
Nephrocalcinosis n n n n y 
Failure to thrive n n n n y 
Mutation n.d. n.d. none none SLC4A1c.1766G>A, 
p.Arg589His 
y: yes, n: no, n.d.: not determined, n/a: not available  
 
 
